

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 6.26038859 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.79243572 |
| 3 | positive regulation of interferon-alpha production (GO:0032727) | 5.46590612 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.29870682 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.26357523 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.21597480 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.21597480 |
| 8 | regulation of interferon-alpha production (GO:0032647) | 5.15621876 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.88547593 |
| 10 | detection of external biotic stimulus (GO:0098581) | 4.80753091 |
| 11 | cellular extravasation (GO:0045123) | 4.74343946 |
| 12 | detection of other organism (GO:0098543) | 4.67593055 |
| 13 | * positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.66236270 |
| 14 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.59164778 |
| 15 | microglial cell activation (GO:0001774) | 4.57705713 |
| 16 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.54066873 |
| 17 | response to peptidoglycan (GO:0032494) | 4.53042290 |
| 18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.52972908 |
| 19 | positive regulation of heat generation (GO:0031652) | 4.40622794 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.40165850 |
| 21 | macrophage activation (GO:0042116) | 4.39458102 |
| 22 | neutrophil mediated immunity (GO:0002446) | 4.31277761 |
| 23 | detection of biotic stimulus (GO:0009595) | 4.29062343 |
| 24 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.27823808 |
| 25 | natural killer cell mediated immunity (GO:0002228) | 4.27823808 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.25442041 |
| 27 | regulation of fever generation (GO:0031620) | 4.23683715 |
| 28 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.17854662 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.16792742 |
| 30 | cellular response to type I interferon (GO:0071357) | 4.03168366 |
| 31 | type I interferon signaling pathway (GO:0060337) | 4.03168366 |
| 32 | response to type I interferon (GO:0034340) | 4.01588103 |
| 33 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.01141892 |
| 34 | reactive oxygen species biosynthetic process (GO:1903409) | 4.00829576 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.00630624 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98030835 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98030835 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.98030835 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98030835 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.98030835 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98030835 |
| 42 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.97913223 |
| 43 | response to host (GO:0075136) | 3.96536082 |
| 44 | response to host defenses (GO:0052200) | 3.96536082 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96536082 |
| 46 | detection of bacterium (GO:0016045) | 3.90820462 |
| 47 | granulocyte activation (GO:0036230) | 3.90405003 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90071243 |
| 49 | respiratory burst (GO:0045730) | 3.89941742 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 3.88576457 |
| 51 | cellular response to zinc ion (GO:0071294) | 3.82852517 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75300423 |
| 53 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.69378573 |
| 54 | positive regulation of interferon-beta production (GO:0032728) | 3.67523039 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.65625159 |
| 56 | myeloid leukocyte mediated immunity (GO:0002444) | 3.65165147 |
| 57 | germinal center formation (GO:0002467) | 3.64452710 |
| 58 | myeloid dendritic cell differentiation (GO:0043011) | 3.62262799 |
| 59 | neutrophil activation (GO:0042119) | 3.61972338 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.60348578 |
| 61 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.56602740 |
| 62 | cellular response to virus (GO:0098586) | 3.55150097 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.54349032 |
| 64 | response to interleukin-15 (GO:0070672) | 3.53225747 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.52840119 |
| 66 | superoxide anion generation (GO:0042554) | 3.51096603 |
| 67 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.50769502 |
| 68 | T-helper 1 type immune response (GO:0042088) | 3.48633362 |
| 69 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.47986609 |
| 70 | cellular response to interferon-alpha (GO:0035457) | 3.47497365 |
| 71 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.45987516 |
| 72 | B cell mediated immunity (GO:0019724) | 3.43766968 |
| 73 | positive regulation of interleukin-12 production (GO:0032735) | 3.41956995 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.40469769 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 3.37765214 |
| 76 | response to interferon-alpha (GO:0035455) | 3.37452554 |
| 77 | low-density lipoprotein particle clearance (GO:0034383) | 3.36451855 |
| 78 | regulation of heat generation (GO:0031650) | 3.35012730 |
| 79 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.32606722 |
| 80 | cellular response to exogenous dsRNA (GO:0071360) | 3.32171219 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.32095923 |
| 82 | leukocyte mediated cytotoxicity (GO:0001909) | 3.31983078 |
| 83 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31911121 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31911121 |
| 85 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30875465 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29712382 |
| 87 | defense response to protozoan (GO:0042832) | 3.29306221 |
| 88 | negative regulation of viral genome replication (GO:0045071) | 3.28246524 |
| 89 | regulation of activation of Janus kinase activity (GO:0010533) | 3.27796857 |
| 90 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.27528808 |
| 91 | leukocyte aggregation (GO:0070486) | 3.27056700 |
| 92 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26581872 |
| 93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.25304244 |
| 94 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23294451 |
| 95 | regulation of RIG-I signaling pathway (GO:0039535) | 3.20162077 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.19873309 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.19873309 |
| 98 | * regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.19317204 |
| 99 | regulation of cholesterol storage (GO:0010885) | 3.17786620 |
| 100 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.17473260 |
| 101 | negative regulation of lipid storage (GO:0010888) | 3.17177003 |
| 102 | cellular response to interferon-beta (GO:0035458) | 3.15436475 |
| 103 | monocyte chemotaxis (GO:0002548) | 3.14214479 |
| 104 | myeloid dendritic cell activation (GO:0001773) | 3.12243990 |
| 105 | positive regulation of type 2 immune response (GO:0002830) | 3.09037628 |
| 106 | cellular response to interleukin-15 (GO:0071350) | 3.08514105 |
| 107 | cytokine secretion (GO:0050663) | 3.08482449 |
| 108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08004180 |
| 109 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.07701801 |
| 110 | neutrophil chemotaxis (GO:0030593) | 3.06481827 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04060666 |
| 112 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.02712653 |
| 113 | positive regulation of chemokine production (GO:0032722) | 3.02580764 |
| 114 | positive regulation of prostaglandin secretion (GO:0032308) | 3.02415636 |
| 115 | regulation of vitamin metabolic process (GO:0030656) | 3.01274000 |
| 116 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99718839 |
| 117 | NIK/NF-kappaB signaling (GO:0038061) | 2.98516937 |
| 118 | neutrophil migration (GO:1990266) | 2.98403930 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.95501173 |
| 120 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.95216814 |
| 121 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.95182760 |
| 122 | regulation of prostaglandin secretion (GO:0032306) | 2.94938715 |
| 123 | myeloid leukocyte activation (GO:0002274) | 2.94610363 |
| 124 | eosinophil chemotaxis (GO:0048245) | 2.93773850 |
| 125 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.93595643 |
| 126 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.93487056 |
| 127 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.93452367 |
| 128 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90129275 |
| 129 | response to interferon-beta (GO:0035456) | 2.88655779 |
| 130 | positive regulation of macrophage cytokine production (GO:0060907) | 2.87769621 |
| 131 | regulation of macrophage cytokine production (GO:0010935) | 2.87228482 |
| 132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.87187158 |
| 133 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86067871 |
| 134 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.85794735 |
| 135 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.85360691 |
| 136 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.85163993 |
| 137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.84210824 |
| 138 | positive regulation of acute inflammatory response (GO:0002675) | 2.83743306 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 2.83440922 |
| 140 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81949493 |
| 141 | positive regulation of mast cell degranulation (GO:0043306) | 2.81949493 |
| 142 | positive regulation of interleukin-2 production (GO:0032743) | 2.80886831 |
| 143 | negative regulation of interleukin-17 production (GO:0032700) | 2.80304843 |
| 144 | regulation of mononuclear cell migration (GO:0071675) | 2.79987364 |
| 145 | negative regulation of B cell mediated immunity (GO:0002713) | 2.79507708 |
| 146 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.79507708 |
| 147 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.79434907 |
| 148 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.79239591 |
| 149 | regulation of mast cell activation (GO:0033003) | 2.79070472 |
| 150 | dendritic cell migration (GO:0036336) | 2.78951652 |
| 151 | response to protozoan (GO:0001562) | 2.77710610 |
| 152 | response to host immune response (GO:0052572) | 2.77567012 |
| 153 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77567012 |
| 154 | growth hormone receptor signaling pathway (GO:0060396) | 2.77511689 |
| 155 | regulation of interleukin-12 production (GO:0032655) | 2.75679855 |
| 156 | B cell receptor signaling pathway (GO:0050853) | 2.75307496 |
| 157 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.75286699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.14574353 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.66900032 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.63172619 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.71141598 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.33209074 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.94925848 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.63269324 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56052278 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45530337 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.44626048 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11284583 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96964024 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71089793 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64402062 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.58658482 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.57304700 |
| 17 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.54992950 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52097396 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48545549 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46805617 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43042430 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34381417 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04643191 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03987271 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.97214203 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86094950 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81349165 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79990107 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63810348 |
| 30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63210517 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.62875909 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55113780 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54761334 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54500694 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53671451 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51705697 |
| 37 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50413354 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.45953383 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43720549 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42658003 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39858594 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37637413 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35923090 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35758335 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34221403 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32493705 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32363278 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32363278 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31566287 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30733966 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30708567 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28209625 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24554329 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.24284260 |
| 55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23061603 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21447063 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18628222 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18435559 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18149991 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.17904293 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17551791 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16631328 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15531640 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11230472 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07800283 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07014079 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06430424 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.05604568 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05290017 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05228111 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05176722 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03794496 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03603631 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02101588 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00992613 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00528783 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99702093 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 0.99494461 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99076435 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98308903 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98006163 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97713794 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97000597 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96029865 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95797925 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95175756 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94765052 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94455286 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93121234 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93121234 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92587464 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92049514 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90960636 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89879708 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89762600 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89486015 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89295168 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89061055 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88906785 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88008195 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87430279 |
| 102 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85511965 |
| 103 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.85081849 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84646273 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84380219 |
| 106 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83767848 |
| 107 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83097279 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81882130 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81479295 |
| 110 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80527902 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80236184 |
| 112 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79392255 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79385196 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78220977 |
| 115 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.77875608 |
| 116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77750775 |
| 117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77730887 |
| 118 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76949262 |
| 119 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76490666 |
| 120 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74977646 |
| 121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74010972 |
| 122 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73828509 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73427921 |
| 124 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73266911 |
| 125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72331866 |
| 126 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.71834564 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71479694 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71398316 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71260865 |
| 130 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.67309519 |
| 131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66676362 |
| 132 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.64984254 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64934505 |
| 134 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.64008527 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.63153285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.39630606 |
| 2 | MP0009785_altered_susceptibility_to | 3.97637678 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.43042004 |
| 4 | MP0003436_decreased_susceptibility_to | 3.31281291 |
| 5 | MP0006082_CNS_inflammation | 3.11058933 |
| 6 | MP0003303_peritoneal_inflammation | 2.91394049 |
| 7 | MP0003724_increased_susceptibility_to | 2.84707100 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.79119115 |
| 9 | MP0002419_abnormal_innate_immunity | 2.77784373 |
| 10 | MP0005025_abnormal_response_to | 2.75011743 |
| 11 | MP0004510_myositis | 2.54734290 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.52510222 |
| 13 | MP0000685_abnormal_immune_system | 2.47315160 |
| 14 | MP0002006_tumorigenesis | 2.40947189 |
| 15 | MP0005387_immune_system_phenotype | 2.34846171 |
| 16 | MP0001790_abnormal_immune_system | 2.34846171 |
| 17 | MP0008260_abnormal_autophagy | 2.33971423 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.26451685 |
| 19 | MP0009764_decreased_sensitivity_to | 2.18827512 |
| 20 | MP0002254_reproductive_system_inflammat | 2.16511126 |
| 21 | MP0005671_abnormal_response_to | 2.12847974 |
| 22 | MP0002723_abnormal_immune_serum | 2.12483508 |
| 23 | MP0003186_abnormal_redox_activity | 2.05995590 |
| 24 | MP0001800_abnormal_humoral_immune | 2.05789621 |
| 25 | MP0003448_altered_tumor_morphology | 2.04656048 |
| 26 | MP0005058_abnormal_lysosome_morphology | 2.00315222 |
| 27 | MP0001853_heart_inflammation | 1.89381293 |
| 28 | MP0001819_abnormal_immune_cell | 1.85171618 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.79684906 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.79296354 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.74755414 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.73971782 |
| 33 | MP0008469_abnormal_protein_level | 1.70728179 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.70318892 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.64769686 |
| 36 | MP0004947_skin_inflammation | 1.62329185 |
| 37 | MP0002132_abnormal_respiratory_system | 1.60032207 |
| 38 | MP0000343_altered_response_to | 1.58891947 |
| 39 | MP0002405_respiratory_system_inflammati | 1.58755373 |
| 40 | MP0008004_abnormal_stomach_pH | 1.58390328 |
| 41 | MP0004883_abnormal_blood_vessel | 1.57502762 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.53319923 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.52811636 |
| 44 | MP0003195_calcinosis | 1.48703656 |
| 45 | MP0000858_altered_metastatic_potential | 1.47596410 |
| 46 | MP0009840_abnormal_foam_cell | 1.46682740 |
| 47 | MP0005310_abnormal_salivary_gland | 1.45462619 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.44725047 |
| 49 | MP0003075_altered_response_to | 1.44344720 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.43653176 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.37991415 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.34579822 |
| 53 | MP0009278_abnormal_bone_marrow | 1.33572799 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.31472380 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.29474429 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.28767151 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.27303422 |
| 58 | MP0003646_muscle_fatigue | 1.27029800 |
| 59 | MP0005166_decreased_susceptibility_to | 1.25373456 |
| 60 | * MP0000716_abnormal_immune_system | 1.22293212 |
| 61 | MP0004381_abnormal_hair_follicle | 1.21021190 |
| 62 | MP0005164_abnormal_response_to | 1.19475140 |
| 63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17242886 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.16092164 |
| 65 | MP0010307_abnormal_tumor_latency | 1.15802540 |
| 66 | MP0009763_increased_sensitivity_to | 1.15751033 |
| 67 | MP0001851_eye_inflammation | 1.15672645 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.15249243 |
| 69 | MP0003866_abnormal_defecation | 1.12653100 |
| 70 | MP0003690_abnormal_glial_cell | 1.07686927 |
| 71 | * MP0002398_abnormal_bone_marrow | 1.04827571 |
| 72 | MP0004130_abnormal_muscle_cell | 1.03957832 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.02444936 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.01772199 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.01772199 |
| 76 | MP0000604_amyloidosis | 1.01497733 |
| 77 | MP0003828_pulmonary_edema | 1.01273389 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.01139282 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.99645202 |
| 80 | * MP0002429_abnormal_blood_cell | 0.95676393 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.94971018 |
| 82 | * MP0000703_abnormal_thymus_morphology | 0.94601000 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.94404105 |
| 84 | MP0003045_fibrosis | 0.94224819 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.93575249 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 0.92403378 |
| 87 | MP0004484_altered_response_of | 0.91250433 |
| 88 | MP0006054_spinal_hemorrhage | 0.90907794 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 0.90713755 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.90635402 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.90372943 |
| 92 | MP0000371_diluted_coat_color | 0.89238958 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.87906592 |
| 94 | MP0005535_abnormal_body_temperature | 0.87834515 |
| 95 | MP0001881_abnormal_mammary_gland | 0.87497985 |
| 96 | MP0000609_abnormal_liver_physiology | 0.87346949 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.86033450 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.85559569 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.83046118 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.81810529 |
| 101 | * MP0002722_abnormal_immune_system | 0.81720092 |
| 102 | MP0000249_abnormal_blood_vessel | 0.80526561 |
| 103 | MP0005360_urolithiasis | 0.78983492 |
| 104 | MP0005408_hypopigmentation | 0.76954900 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.76543080 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.74174301 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.74069603 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72535169 |
| 109 | MP0001873_stomach_inflammation | 0.71151842 |
| 110 | MP0001663_abnormal_digestive_system | 0.70115381 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.68908428 |
| 112 | MP0008874_decreased_physiological_sensi | 0.68898717 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.68813011 |
| 114 | MP0003091_abnormal_cell_migration | 0.66475983 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.66158779 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.65969459 |
| 117 | MP0009115_abnormal_fat_cell | 0.65712267 |
| 118 | MP0005451_abnormal_body_composition | 0.64445351 |
| 119 | MP0005390_skeleton_phenotype | 0.63550657 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.63214779 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.63176655 |
| 122 | MP0000598_abnormal_liver_morphology | 0.61611384 |
| 123 | MP0003795_abnormal_bone_structure | 0.61183838 |
| 124 | MP0002971_abnormal_brown_adipose | 0.60384646 |
| 125 | MP0003329_amyloid_beta_deposits | 0.52435926 |
| 126 | MP0005023_abnormal_wound_healing | 0.51350979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.56858076 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.42973646 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.01662455 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.01645738 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.07884075 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.92772185 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.89274355 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 4.77603461 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.18335130 |
| 10 | Gingivitis (HP:0000230) | 4.08634671 |
| 11 | Recurrent skin infections (HP:0001581) | 3.86541687 |
| 12 | Tetraparesis (HP:0002273) | 3.83249892 |
| 13 | Increased IgM level (HP:0003496) | 3.78375345 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.66204345 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.58347451 |
| 16 | Peritonitis (HP:0002586) | 3.52934730 |
| 17 | Encephalitis (HP:0002383) | 3.50774509 |
| 18 | T lymphocytopenia (HP:0005403) | 3.48994215 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.43136913 |
| 20 | Basal ganglia calcification (HP:0002135) | 3.35270726 |
| 21 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.33487485 |
| 22 | Vasculitis (HP:0002633) | 3.29116064 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.28345234 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.28067735 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.26277359 |
| 26 | Axonal loss (HP:0003447) | 3.25772815 |
| 27 | Orchitis (HP:0100796) | 3.25403343 |
| 28 | Stomatitis (HP:0010280) | 3.23721812 |
| 29 | Myositis (HP:0100614) | 3.22885839 |
| 30 | Gangrene (HP:0100758) | 3.20969112 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 3.08926613 |
| 32 | Amyloidosis (HP:0011034) | 3.07532188 |
| 33 | Anorexia (HP:0002039) | 3.05564362 |
| 34 | Chest pain (HP:0100749) | 3.03808896 |
| 35 | Obstructive lung disease (HP:0006536) | 3.02141182 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02141182 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98299625 |
| 38 | Episodic fever (HP:0001954) | 2.97751880 |
| 39 | Hematochezia (HP:0002573) | 2.91764504 |
| 40 | Cellulitis (HP:0100658) | 2.90678652 |
| 41 | Pulmonary embolism (HP:0002204) | 2.89955287 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 2.89541488 |
| 43 | Hydroxyprolinuria (HP:0003080) | 2.89541488 |
| 44 | Increased IgE level (HP:0003212) | 2.87404021 |
| 45 | Recurrent viral infections (HP:0004429) | 2.86803436 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85306766 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85306766 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.82558274 |
| 49 | Optic neuritis (HP:0100653) | 2.82558274 |
| 50 | Nausea (HP:0002018) | 2.80561704 |
| 51 | Periodontitis (HP:0000704) | 2.72954805 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.72456782 |
| 53 | Prostate neoplasm (HP:0100787) | 2.68691583 |
| 54 | Subacute progressive viral hepatitis (HP:0006572) | 2.68028820 |
| 55 | Urticaria (HP:0001025) | 2.66830727 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.65003275 |
| 57 | Abnormality of the pleura (HP:0002103) | 2.62215006 |
| 58 | Myocardial infarction (HP:0001658) | 2.60876167 |
| 59 | Esophageal varix (HP:0002040) | 2.54381707 |
| 60 | Abnormality of the endocardium (HP:0004306) | 2.54173751 |
| 61 | Abnormality of the peritoneum (HP:0002585) | 2.53341132 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.52277649 |
| 63 | Disinhibition (HP:0000734) | 2.49570738 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.49427761 |
| 65 | Neoplasm of head and neck (HP:0012288) | 2.49238050 |
| 66 | Esophageal neoplasm (HP:0100751) | 2.49238050 |
| 67 | Abnormality of T cells (HP:0002843) | 2.48419711 |
| 68 | Osteomyelitis (HP:0002754) | 2.47895315 |
| 69 | Premature loss of primary teeth (HP:0006323) | 2.44341680 |
| 70 | Thick nail (HP:0001805) | 2.43287344 |
| 71 | Epistaxis (HP:0000421) | 2.42881756 |
| 72 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42658404 |
| 73 | Keratitis (HP:0000491) | 2.40749056 |
| 74 | Pulmonary infiltrates (HP:0002113) | 2.39994098 |
| 75 | Glomerulopathy (HP:0100820) | 2.37123484 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.36914737 |
| 77 | Glomerulonephritis (HP:0000099) | 2.31060551 |
| 78 | Porencephaly (HP:0002132) | 2.29606705 |
| 79 | Osteolytic defects of the hand bones (HP:0009699) | 2.28806467 |
| 80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28806467 |
| 81 | Agnosia (HP:0010524) | 2.28620139 |
| 82 | Hepatosplenomegaly (HP:0001433) | 2.26239219 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25868327 |
| 84 | Granulocytopenia (HP:0001913) | 2.24926786 |
| 85 | Gingival bleeding (HP:0000225) | 2.24619197 |
| 86 | Bone pain (HP:0002653) | 2.22272152 |
| 87 | Vertigo (HP:0002321) | 2.21606622 |
| 88 | Eosinophilia (HP:0001880) | 2.20711457 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20663081 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19610652 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.18863339 |
| 92 | Nephritis (HP:0000123) | 2.18205584 |
| 93 | Pathologic fracture (HP:0002756) | 2.15032873 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.14170941 |
| 95 | Chronic otitis media (HP:0000389) | 2.14038061 |
| 96 | Polyneuropathy (HP:0001271) | 2.13554594 |
| 97 | Hypoglycemic coma (HP:0001325) | 2.13531861 |
| 98 | Increased serum ferritin (HP:0003281) | 2.12060622 |
| 99 | Petechiae (HP:0000967) | 2.11332718 |
| 100 | Loss of speech (HP:0002371) | 2.09824868 |
| 101 | Acne (HP:0001061) | 2.09027286 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.08802410 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.08792902 |
| 104 | Arterial thrombosis (HP:0004420) | 2.08369385 |
| 105 | Pustule (HP:0200039) | 2.08330711 |
| 106 | Sepsis (HP:0100806) | 2.06798422 |
| 107 | Joint swelling (HP:0001386) | 2.05969669 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05583727 |
| 109 | Viral hepatitis (HP:0006562) | 2.05443545 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05389075 |
| 111 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05389075 |
| 112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05389075 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.04468409 |
| 114 | Acute hepatic failure (HP:0006554) | 2.03442676 |
| 115 | Leukocytosis (HP:0001974) | 2.03165559 |
| 116 | Thrombophlebitis (HP:0004418) | 2.02639024 |
| 117 | Mucosal telangiectasiae (HP:0100579) | 2.02248348 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02125318 |
| 119 | Colitis (HP:0002583) | 2.00861582 |
| 120 | Hemoptysis (HP:0002105) | 2.00027635 |
| 121 | Abnormality of T cell number (HP:0011839) | 1.99580779 |
| 122 | Joint hemorrhage (HP:0005261) | 1.96688134 |
| 123 | Recurrent bronchitis (HP:0002837) | 1.95442381 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.95013707 |
| 125 | Cheilitis (HP:0100825) | 1.94092528 |
| 126 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92555652 |
| 127 | Gastrointestinal inflammation (HP:0004386) | 1.92154479 |
| 128 | Parakeratosis (HP:0001036) | 1.91173594 |
| 129 | IgA deficiency (HP:0002720) | 1.90985530 |
| 130 | Hypochromic anemia (HP:0001931) | 1.90837576 |
| 131 | Abnormality of the pericardium (HP:0001697) | 1.90399708 |
| 132 | Abnormality of T cell physiology (HP:0011840) | 1.89351340 |
| 133 | Abnormality of the basal ganglia (HP:0002134) | 1.89172524 |
| 134 | Keratoconjunctivitis (HP:0001096) | 1.89093803 |
| 135 | Upper motor neuron abnormality (HP:0002127) | 1.88136467 |
| 136 | Meningitis (HP:0001287) | 1.88081306 |
| 137 | Purpura (HP:0000979) | 1.86600141 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.85941299 |
| 139 | Prolonged neonatal jaundice (HP:0006579) | 1.84857620 |
| 140 | Poor head control (HP:0002421) | 1.84057259 |
| 141 | Bone cyst (HP:0012062) | 1.83799022 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83733377 |
| 143 | Skin ulcer (HP:0200042) | 1.83664364 |
| 144 | Progressive visual loss (HP:0000529) | 1.83229023 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.82000562 |
| 146 | Fatigue (HP:0012378) | 1.81336891 |
| 147 | Hypochromic microcytic anemia (HP:0004840) | 1.80596654 |
| 148 | Amaurosis fugax (HP:0100576) | 1.78300393 |
| 149 | Abnormality of eosinophils (HP:0001879) | 1.77544297 |
| 150 | Alveolar cell carcinoma (HP:0006519) | 1.74817767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.25012011 |
| 2 | PBK | 5.19011772 |
| 3 | TBK1 | 3.70028692 |
| 4 | RIPK4 | 3.48608151 |
| 5 | TYK2 | 2.92295965 |
| 6 | BLK | 2.86126343 |
| 7 | IRAK3 | 2.64670311 |
| 8 | IRAK4 | 2.55443035 |
| 9 | IKBKE | 2.55235267 |
| 10 | JAK3 | 2.53101531 |
| 11 | IKBKB | 2.40734661 |
| 12 | EPHB1 | 2.14041722 |
| 13 | MST4 | 2.12782045 |
| 14 | EPHA3 | 2.04565679 |
| 15 | JAK1 | 2.02662530 |
| 16 | CHUK | 1.84164768 |
| 17 | FES | 1.80117076 |
| 18 | FGFR4 | 1.71833307 |
| 19 | PRPF4B | 1.68633060 |
| 20 | TXK | 1.67957612 |
| 21 | BMX | 1.67773131 |
| 22 | GRK6 | 1.63187416 |
| 23 | MST1R | 1.60532777 |
| 24 | FGFR3 | 1.57721994 |
| 25 | MAP3K13 | 1.56848570 |
| 26 | ERN1 | 1.55352654 |
| 27 | TAOK1 | 1.53016736 |
| 28 | MAP3K2 | 1.52954871 |
| 29 | PIM2 | 1.51518922 |
| 30 | TAOK3 | 1.50492115 |
| 31 | MAP4K1 | 1.47993115 |
| 32 | SIK3 | 1.44655892 |
| 33 | ABL2 | 1.38895106 |
| 34 | RPS6KA4 | 1.33664783 |
| 35 | KIT | 1.31885643 |
| 36 | NEK9 | 1.31650629 |
| 37 | PIM1 | 1.30307809 |
| 38 | STK4 | 1.28196179 |
| 39 | JAK2 | 1.26671649 |
| 40 | MAP3K6 | 1.26256386 |
| 41 | MET | 1.16814397 |
| 42 | CSK | 1.14464003 |
| 43 | TTN | 1.12302050 |
| 44 | TNK2 | 1.11503152 |
| 45 | FGR | 1.10928791 |
| 46 | MAP3K11 | 1.08957887 |
| 47 | RIPK1 | 1.07304687 |
| 48 | GRK7 | 1.04770704 |
| 49 | TAOK2 | 1.03799315 |
| 50 | ZAP70 | 1.03735705 |
| 51 | NLK | 1.03352810 |
| 52 | BMPR2 | 1.02303539 |
| 53 | KSR1 | 1.01534355 |
| 54 | IRAK1 | 1.00965019 |
| 55 | SYK | 0.98259682 |
| 56 | HCK | 0.97941558 |
| 57 | ERBB4 | 0.90497334 |
| 58 | CSF1R | 0.85860731 |
| 59 | EIF2AK2 | 0.82868069 |
| 60 | MARK3 | 0.82484660 |
| 61 | WNK1 | 0.82114711 |
| 62 | RAF1 | 0.80649616 |
| 63 | TRPM7 | 0.77258798 |
| 64 | FLT3 | 0.77110255 |
| 65 | FRK | 0.74405241 |
| 66 | LYN | 0.71251429 |
| 67 | NME2 | 0.71163071 |
| 68 | MAP3K5 | 0.70728675 |
| 69 | LCK | 0.70646965 |
| 70 | KDR | 0.70469696 |
| 71 | MARK2 | 0.68590144 |
| 72 | STK10 | 0.67591473 |
| 73 | SGK3 | 0.67577702 |
| 74 | BTK | 0.67212768 |
| 75 | PKN2 | 0.66249559 |
| 76 | MATK | 0.66134825 |
| 77 | ABL1 | 0.63926559 |
| 78 | PTK6 | 0.63860156 |
| 79 | ERBB3 | 0.63490467 |
| 80 | EGFR | 0.62903536 |
| 81 | CDC42BPA | 0.62852216 |
| 82 | MAP2K6 | 0.62135053 |
| 83 | CLK1 | 0.61369364 |
| 84 | TEC | 0.59846583 |
| 85 | BCR | 0.58941879 |
| 86 | MOS | 0.58840902 |
| 87 | PRKCD | 0.57633099 |
| 88 | LRRK2 | 0.57624073 |
| 89 | STK24 | 0.57092591 |
| 90 | YES1 | 0.55256331 |
| 91 | MAP2K4 | 0.55150700 |
| 92 | PDK2 | 0.54740058 |
| 93 | TGFBR2 | 0.54430675 |
| 94 | SGK2 | 0.53655150 |
| 95 | DYRK3 | 0.53509856 |
| 96 | ALK | 0.52021249 |
| 97 | FYN | 0.51484216 |
| 98 | CDK6 | 0.49311262 |
| 99 | STK3 | 0.48753481 |
| 100 | PIK3CG | 0.48576401 |
| 101 | BCKDK | 0.44980181 |
| 102 | MAP2K3 | 0.44251354 |
| 103 | RPS6KA5 | 0.43589596 |
| 104 | HIPK2 | 0.42908783 |
| 105 | PRKCQ | 0.42034870 |
| 106 | RET | 0.41767089 |
| 107 | STK38 | 0.40512109 |
| 108 | GSK3A | 0.38174894 |
| 109 | MAPK7 | 0.37476215 |
| 110 | MAPKAPK2 | 0.37081209 |
| 111 | ITK | 0.35285738 |
| 112 | MAP3K3 | 0.35114080 |
| 113 | STK11 | 0.34939663 |
| 114 | PDPK1 | 0.34887674 |
| 115 | CDK12 | 0.34439977 |
| 116 | TGFBR1 | 0.33897603 |
| 117 | CDK4 | 0.33602862 |
| 118 | MAP3K1 | 0.33031306 |
| 119 | PRKD2 | 0.32748021 |
| 120 | PDK1 | 0.32462627 |
| 121 | PDGFRB | 0.31165312 |
| 122 | MAP3K7 | 0.31158895 |
| 123 | ARAF | 0.31101292 |
| 124 | CAMKK2 | 0.29354241 |
| 125 | KSR2 | 0.28762120 |
| 126 | DAPK3 | 0.28660584 |
| 127 | IGF1R | 0.28054352 |
| 128 | INSR | 0.27847682 |
| 129 | DYRK1B | 0.27706048 |
| 130 | DAPK2 | 0.27295582 |
| 131 | ACVR1B | 0.27149807 |
| 132 | PRKAA2 | 0.26352195 |
| 133 | RPS6KA1 | 0.25415576 |
| 134 | MAPK12 | 0.25411551 |
| 135 | PTK2B | 0.23779921 |
| 136 | IRAK2 | 0.22582277 |
| 137 | MAP3K8 | 0.21772659 |
| 138 | SCYL2 | 0.18591124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.21472586 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.29376633 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.81274297 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.79816625 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.78068261 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77171333 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71772136 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.69486720 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.69317190 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.67707215 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.32032131 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.26815329 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17647638 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.13092251 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.12241561 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.01366256 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.97958997 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.97057965 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.89719873 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89101279 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87115070 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.83128627 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81012572 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.80578987 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.59829251 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56978118 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51894249 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.36233349 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35085704 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31770203 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.24604191 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14673199 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13535036 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.13520049 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10689203 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08323595 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08101611 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07229284 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07160163 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06221696 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04606083 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.03120428 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02475104 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.01571796 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01351868 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99185897 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98550897 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97302566 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95894201 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94856134 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92742960 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92047166 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89439425 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.89182996 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.88287966 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.84613107 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84104075 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75824637 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.75816386 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70741100 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68702752 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66855400 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65657117 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64285044 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63018707 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62363641 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61016318 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60690204 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58056145 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57674630 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57362976 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57317473 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.56264015 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54256569 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53913491 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.53881587 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53876292 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53445332 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.53012715 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52785896 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52574224 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52190218 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.51564024 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.51060315 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50567527 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49595086 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49436020 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.48007544 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47985573 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47698283 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46817638 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45908780 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44863186 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44019949 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42992091 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42564284 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42340334 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42339697 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41226802 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41121157 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41054801 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40115489 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38338918 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38283884 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37344105 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.36029776 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35285653 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35098668 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34860881 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34493649 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34117834 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34069108 |
| 113 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34062171 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34051728 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34013508 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33957473 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33718396 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32856561 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31860136 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31496028 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31105520 |
| 122 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31034012 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30391668 |
| 124 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29583436 |
| 125 | Proteasome_Homo sapiens_hsa03050 | 0.29488743 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25234533 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24606161 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24429603 |
| 129 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.22751963 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21574367 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19235020 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18234666 |

